Skip to content
Screener

Replimune Group REPL Total Current Assets

Total Current Assets at other companies

Amgen logo
AmgenAMGN
$34.96B+30.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$18.45B+9.4%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$197.75M+112%
Regenxbio logo
RegenxbioRGNX
$236.16M-36.8%
Immunome logo
ImmunomeIMNM
$594.31M+83.9%
CG Oncology logo
CG OncologyCGON
$1.05B+56.0%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$1.01B+160%
Enterprise value$967.91M+162%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Replimune Group’s 10-Q, filed February 3, 2026.

Filed
Feb 3, 2026, 8:12 AM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q4 2025
Accession
0001628280-26-004805
Line itemDecember 31, 2025March 31, 2025
Short-term investments146,186372,685
Research and development incentives receivable2,9553,725
Prepaid expenses and other current assets8,2628,351
Total current assets280,354495,880
Property, plant and equipment, net13,84713,739
Restricted cash1,7041,703
Other non-current assets1,2001,200
Right-of-use asset - operating leases3,4983,998

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Replimune Group's total current assets?
Replimune Group (REPL) reported total current assets of $280.35M in Q4 2025.
How has Replimune Group's total current assets changed year-over-year?
Replimune Group's total current assets decreased by 48.8% year-over-year, from $547.58M to $280.35M.
What is the long-term trend for Replimune Group's total current assets?
Over 4 years (2021 to 2025), Replimune Group's total current assets has grown at a 0.6% compound annual growth rate (CAGR), from $483.75M to $495.88M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Replimune Group's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude